FDA’s LDT Review Clears OMB Review, But Shutdown Could Delay It

By Jessica Karins / September 28, 2023 at 4:51 PM
FDA has received the nod from the White House budget office to propose a controversial rule asserting the agency’s authority to regulate laboratory developed tests (LDTs), but a potential government shutdown should Congress not fund the government starting Oct. 1 could delay the rulemaking process. The White House Office of Management and Budget concluded its review of the rule Tuesday (Sept. 26), clearing the way for FDA to issue a Federal Register notice. However, as of Thursday (Sept. 28),...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.